Intranasal Drug Delivery Devices Market Outlook 2024-2033: Trends and Projections
Intranasal Drug Delivery Devices Market Expansion 2024-2033: Growth Drivers and Dynamics
Global Intranasal Drug Delivery Devices Market Analysis 2024: Size Forecast and Growth Prospects
Intranasal Drug Delivery Devices Market 2024-2033: Technological Advancements, Competitive Landscape and Strategies
Global Intranasal Drug Delivery Devices Market Overview 2024: Size, Growth Rate, and Segments
intranasal drug delivery devices market analysis, intranasal drug delivery devices market drivers, intranasal drug delivery devices market top players, intranasal drug delivery devices market overview, intranasal drug delivery devices market growth, intranasal drug delivery devices market report, intranasal drug delivery devices global market, intranasal drug delivery devices industry analysis, intranasal drug delivery devices market outlook, intranasal drug delivery devices market research
The intranasal drug delivery devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Intranasal Drug Delivery Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $55.27 billion in 2023 to $60.27 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications..
The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $84.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies.. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report
Scope Of Intranasal Drug Delivery Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Intranasal Drug Delivery Devices Market Overview
Market Drivers –
The increasing prevalence of chronic diseases is expected to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases can be defined as conditions that last 1 year or more and require ongoing medical attention, limit activities of daily living, or both. Intranasal drug delivery devices are used to manage chronic diseases by providing a non-invasive and efficient way to administer medications. They allow medications to be delivered directly to the affected area, which is convenient, making it easy to use and promoting rapid absorption. For instance, in September 2022, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market.
Market Trends –
Major pharmaceutical companies operating in the nasal drug delivery technology market are involved in developing new and improved products to provide their customers with new methods of drug administration to sustain their position in the market. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, launched the first recyclable, metal-free, multidose nasal spray, APF Futurity, to deliver nasal saline and other equivalent over-the-counter (OTC) formulations. APF Futurity is manufactured from polyolefin materials and does not include any metal components or recycling disruptors. This reduces the need for separation in recycling streams and promotes a greater grade of recycled materials. This product’s unique feature is its recyclability design; it is a highly recyclable nasal spray pump that has received Class AA certification from cyclos-HTP for recycling streams in Europe.
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Get an inside scoop of the intranasal drug delivery devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
Regional Insights –
North America was the largest region in the intranasal drug delivery devices market in 2023. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies , Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation
Table of Contents
1. Executive Summary
2. Intranasal Drug Delivery Devices Market Report Structure
3. Intranasal Drug Delivery Devices Market Trends And Strategies
4. Intranasal Drug Delivery Devices Market – Macro Economic Scenario
5. Intranasal Drug Delivery Devices Market Size And Growth
…..
27. Intranasal Drug Delivery Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
